# triamterene and hydrochlorothiazide

NDC: 70771-1362
Generic name: triamterene and hydrochlorothiazide
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180904

FDA application: ANDA208360

## Active ingredients

- HYDROCHLOROTHIAZIDE: 50 mg/1
- TRIAMTERENE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1362"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1362
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af80800-e7a5-42e5-aa6c-3f61aff4a77b